Alzheimer Disease Anti-Amyloid Immunotherapies: Imaging Recommendations and Practice Considerations for Monitoring of Amyloid-Related Imaging Abnormalities

^aFrom the Department of Radiology (P.M.C., C.R.J., J.J.P.), Mayo Clinic, Rochester, Minnesota
^bDepartment of Radiology (T.J.A., C.A.R., T.S.B.), Washington University School of Medicine, St. Louis, Missouri
^cDepartment of Radiology (J.A.B.), California Pacific Medical Center, San Francisco, California
^dDepartment of Radiology (F.B.), VU University Medical Center, Amsterdam, The Netherlands
^eQueen Square Institute of Neurology and Centre for Medical Image Computing (F.B.), University College London, UK.
^fRadNet Imaging Centers (S.B., L.T.), Los Angeles, California
^gDepartments of Radiology (M.D.B., C.T.W.), Wake Forest School of Medicine, Winston-Salem, North Carolina
^hDepartment of Radiology (G.C.C.), Weill Cornell Imaging and New York Presbyterian, New York, New York
ⁱDepartment of Radiology (A.M.F.), Northwell Health, New York, New York
^jDepartment of Radiology (T.Y.P.), Boston Children’s Hospital, Boston, Massachusetts
^kDepartment of Neurology (C.A.R.), Washington University School of Medicine, St. Louis, Missouri
^lDepartment of Neurology (V.K.R.), Mayo Clinic, Rochester, Minnesota
^mUC Health (J.T.), University of Colorado Hospital, Aurora, Colorado
ⁿDepartment of Biomedical Engineering (C.T.W.), Wake Forest School of Medicine, Winston-Salem, North Carolina
^oDepartment of Radiology (F.F.Y.), Utah Southwestern Medical Center, Dallas, Texas
^pDepartment of Radiology (G.Z., M.Z.), Stanford Health Care, Stanford Medicine Children’s Hospital, Stanford, California
^qDepartment of Neurosurgery (T.S.B.), Washington University School of Medicine, St. Louis, Missouri